Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
VENLAFAXINA RETARD KERN PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG
Capsule
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- VENLAFAXINA HIDROCLORURO — 150 mg
- Pharmaceutical form Home Med Cabinet grouping
- Capsule
- Availability in Spain
- 1 of 4 packs marketed
Packs
VENLAFAXINA RETARD KERN PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 500 cápsulas
500 pcs
National code
Not marketed605944Strength of this pack 150 mg
VENLAFAXINA RETARD KERN PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas
30 pcs
National code
Not marketed693268Strength of this pack 150 mg
VENLAFAXINA RETARD KERN PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 1 cápsula
1 pcs
National code
Not marketed693269Strength of this pack 150 mg
VENLAFAXINA RETARD KERN PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas
30 pcs
National code
Marketed712583Strength of this pack 150 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 76506Official data
- Marketing authorisation holder
- KERN PHARMA S.L.Official data
- Authorised
- Sep 24, 2012Official data
- Authority form code
- 36Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.